religion
Isolation and characterization of yuremamine, a new phytoindole.
Submitted by Site Editor on Fri, 2006-06-09 07:15.Isolation and characterization of yuremamine, a new phytoindole.: Planta Med. 2005 Nov;71(11):1053-7 Authors: Vepsäläinen JJ, Auriola S, Tukiainen M, Ropponen N, Callaway JC
Yuremamine was isolated and characterized from the stem bark of Mimosa tenuiflora. This plant is still used by indigenous peoples in North-eastern Brazil to make yurema, a psychoactive beverage that is used for medico-religious purpose ( jurema preta or vinho da jurema, in Portuguese). The characterization of this novel compound by NMR and mass spectrometry introduces a new class of phytoindoles.
Hallucinogenic botanicals of America: A growing need for focused drug education and research.
Submitted by Site Editor on Fri, 2006-06-09 03:26.Hallucinogenic botanicals of America: A growing need for focused drug education and research: Halpern JH, Sewell RA. Biological Psychiatry Laboratory, Alcohol and Drug Abuse Research Center, Harvard Medical School.
Botanical sources for medicines in America have been known since long before the arrival of Columbus. Nevertheless, both scientists and the general public are often unaware that some of these botanical drugs are also potent intoxicants. We provide a quick overview of hallucinogenic and dissociative drugs harvested from nature or that are openly and legally cultivated in the United States. Examples of harmful outcomes reported in the media are contrasted with existing responsible ingestion by others, some of whom have the protected right to do so for traditional or sacramental religious purposes. Despite an ongoing and expensive effort to warn people of the potential harms of recreational drug use, little is known about the extent of use of these psychoactive botanicals, and the recent explosion of information available via the Internet could herald a storm of morbidity to come. Mounting more targeted research and educational efforts today may reduce later use and abuse, inform society about the special circumstances of religious use, and better prepare clinicians and other health care providers about the issues involved when people choose to indigenously source psychoactive drugs for human consumption.
